NM_003999.3:c.-14+4400G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003999.3(OSMR):c.-14+4400G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.247 in 152,090 control chromosomes in the GnomAD database, including 4,891 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.25 ( 4891 hom., cov: 32)
Consequence
OSMR
NM_003999.3 intron
NM_003999.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.66
Publications
5 publications found
Genes affected
OSMR (HGNC:8507): (oncostatin M receptor) This gene encodes a member of the type I cytokine receptor family. The encoded protein heterodimerizes with interleukin 6 signal transducer to form the type II oncostatin M receptor and with interleukin 31 receptor A to form the interleukin 31 receptor, and thus transduces oncostatin M and interleukin 31 induced signaling events. Mutations in this gene have been associated with familial primary localized cutaneous amyloidosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
OSMR Gene-Disease associations (from GenCC):
- amyloidosis, primary localized cutaneous, 1Inheritance: SD, AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- familial primary localized cutaneous amyloidosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.383 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.248 AC: 37635AN: 151972Hom.: 4896 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
37635
AN:
151972
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.247 AC: 37627AN: 152090Hom.: 4891 Cov.: 32 AF XY: 0.247 AC XY: 18350AN XY: 74346 show subpopulations
GnomAD4 genome
AF:
AC:
37627
AN:
152090
Hom.:
Cov.:
32
AF XY:
AC XY:
18350
AN XY:
74346
show subpopulations
African (AFR)
AF:
AC:
8039
AN:
41470
American (AMR)
AF:
AC:
4174
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
1223
AN:
3470
East Asian (EAS)
AF:
AC:
891
AN:
5180
South Asian (SAS)
AF:
AC:
1917
AN:
4820
European-Finnish (FIN)
AF:
AC:
2079
AN:
10574
Middle Eastern (MID)
AF:
AC:
94
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18372
AN:
67996
Other (OTH)
AF:
AC:
597
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1435
2870
4305
5740
7175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
410
820
1230
1640
2050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1018
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.